Evidence map›Paper›PMID 25918731›Full record

ArticleJournal of diabetes research2015

Nuclear factor of activated T cells is activated in the endothelium of retinal microvessels in diabetic mice.

Anna V Zetterqvist, Fabiana Blanco, Jenny Öhman, Olga Kotova, Lisa M Berglund, Sergio de Frutos Garcia, Raed Al-Naemi, Maria Wigren, Paul G McGuire, Laura V Gonzalez Bosc and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Role of NFAT in the Progression of Diabetic Atherosclerosis.Frontiers in cardiovascular medicine · 2021
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Maintenance of normal blood pressure is dependent on IP3R1-mediated regulation of eNOS.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Anna V ZetterqvistDepartment of Clinical Sciences in Malmö, Lund University, 20502 Malmö, Sweden.
Fabiana BlancoDepartment of Clinical Sciences in Malmö, Lund University, 20502 Malmö, Sweden ; Departamento de Biofísica, Facultad de Medicina, Universidad de la República, 11800 Montevideo, Uruguay.
Jenny ÖhmanDepartment of Clinical Sciences in Malmö, Lund University, 20502 Malmö, Sweden.
Olga KotovaDepartment of Clinical Sciences in Malmö, Lund University, 20502 Malmö, Sweden.
Lisa M BerglundDepartment of Clinical Sciences in Malmö, Lund University, 20502 Malmö, Sweden.
Sergio de Frutos GarciaDepartment of Cell Biology and Physiology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
Raed Al-NaemiDepartment of Clinical Sciences in Malmö, Lund University, 20502 Malmö, Sweden.
Maria WigrenDepartment of Clinical Sciences in Malmö, Lund University, 20502 Malmö, Sweden.
Paul G McGuireDepartment of Cell Biology and Physiology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
Laura V Gonzalez BoscDepartment of Cell Biology and Physiology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
Maria F GomezDepartment of Clinical Sciences in Malmö, Lund University, 20502 Malmö, Sweden.
Lund University · SEUniversity of New Mexico · USUniversidad de la República · UY

Funding

NFATc3 in chronic hypoxic pulmonary hypertensionR01HL088151 · NHLBI · UNIVERSITY OF NEW MEXICO · PI GONZALEZ BOSC, LAURA V · 2008 to 2012
$2.0M
NHLBI NIH HHS R01 HL088151
6 · The paper itself

Abstract

The pathogenesis of diabetic retinopathy (DR) remains unclear but hyperglycemia is an established risk factor. Endothelial dysfunction and changes in Ca2+ signaling have been shown to precede the onset of DR. We recently demonstrated that high extracellular glucose activates the Ca(2+)/calcineurin-dependent transcription factor NFAT in cerebral arteries and aorta, promoting the expression of inflammatory markers. Here we show, using confocal immunofluorescence, that NFAT is expressed in the endothelium of retinal microvessels and is readily activated by high glucose. This was inhibited by the NFAT blocker A-285222 as well as by the ectonucleotidase apyrase, suggesting a mechanism involving the release of extracellular nucleotides. Acute hyperglycemia induced by an IP-GTT (intraperitoneal glucose tolerance test) resulted in increased NFATc3 nuclear accumulation and NFAT-dependent transcriptional activity in retinal vessels of NFAT-luciferase reporter mice. In both Akita (Ins2(+/-) ) and streptozotocin- (STZ-) induced diabetic mice, NFAT transcriptional activity was elevated in retinal vessels. In vivo inhibition of NFAT with A-285222 decreased the expression of OPN and ICAM-1 mRNA in retinal vessels, prevented a diabetes driven downregulation of anti-inflammatory IL-10 in retina, and abrogated the increased vascular permeability observed in diabetic mice. Results identify NFAT signaling as a putative target for treatment of microvascular complications in diabetes.

Indexed as

AnimalsAortaCalciumDiabetes ComplicationsDiabetes Mellitus, ExperimentalEndothelium, VascularGlucose Tolerance TestHyperglycemiaInflammationIntercellular Adhesion Molecule-1MiceMice, Inbred C57BLMice, TransgenicMicrocirculationMicrovesselsNFATC Transcription FactorsA 285222CalciumIcam1 protein, mouseIntercellular Adhesion Molecule-1Nfatc1 protein, mouseNfatc2 protein, mouseNfatc3 protein, mouseNfatc4 protein, mouseNFATC Transcription FactorsOsteopontinPyrazoles

Identifiers

PMID25918731
PMCPMC4396720
OpenAlexW2059987464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.